Literature DB >> 630794

Ticrynafen, a uricosuric antihypertensive diuretic.

R M Stote, J W Dubb, R G Familiar, F Alexander.   

Abstract

Ticrynafen, a diuretic-uricosuric also effective as an antihypertensive, was compared in single doses with several other diuretics. Over an 8-hr period, a 250- mg dose exerted natriuretic activity comparable to that of 25 mg of chlorthalidone and 50 mg of ethacrynic acid; a 500-mg dose was comparable to 50 mg chlorthalidone and 50 mg hydrochlorothiazide. Ticrynafen combined with furosemide had an additive effect, whereas a combination with hydrochlorothiazide was not additive. In both doses ticrynafen was a uricosuric and this effect was maintained when given with furosemide and hydrochlorothiazide, both of which individually were slightly antiuricosuric. Ticrynafen may be useful in patients requiring a diuretic in whom it is desirable to avoid hyperuricemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630794     DOI: 10.1002/cpt1978234456

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Long term treatment with tienilic acid or thiazides: comparison of antihypertensive and metabolic effects.

Authors:  L A Ferrara; A Siani; P Strazzullo; F Galletti
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Uric acid, diuretics and the kidney.

Authors: 
Journal:  West J Med       Date:  1978-11

3.  Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts.

Authors:  A F Lant
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

4.  Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196).

Authors:  B A Brooks; E M Blair; R Finch; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

5.  Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.